PortViewPortView
Impax Laboratories logo

Impax Laboratories (IPXL) Stock Analysis

NASDAQHealthcareMedical - Pharmaceuticals

$18.30+0.55%
52-week range$18.30
$13.00$25.70

What Impax Laboratories does

Impax Laboratories, Inc. is a specialized pharmaceutical firm distinguished by its technological foundation. Its primary endeavors involve the research and development, production, and market introduction of precision drug delivery mechanisms, generic drug compositions, and proprietary branded medications. The company's activities are organized into two key operational units: Impax Generics and Impax Specialty Pharma.

Key metrics

Market cap
$0
P/E (TTM)
-10.11
EPS (TTM)
$-1.81
Beta
1.27
Dividend yield
0.00%
Revenue / share
$10.80
50-day avg
$19.60
200-day avg
$19.16
52-week high
$25.70
52-week low
$13.00

ETFs linked to IPXL

Broad-market and Healthcare sector ETFs an investor holding Impax Laboratories is often also exposed to. Open an ETF page to see its actual top holdings.

PortView Portfolio Insights

PortView analyzes how IPXL fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Analyze IPXL in PortView →

Similar companies

Frequently asked questions

What is the ticker symbol for Impax Laboratories?
Impax Laboratories trades under the ticker IPXL on NASDAQ.
Which exchange is IPXL listed on?
IPXL is listed on NASDAQ.
What sector does Impax Laboratories operate in?
Impax Laboratories is classified in the Healthcare sector (Medical - Pharmaceuticals industry).
How can PortView help analyze IPXL in a portfolio?
PortView shows IPXL's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.